{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T10:51:10Z","timestamp":1720781470867},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T00:00:00Z","timestamp":1711152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bonr.2024.101754","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T13:31:45Z","timestamp":1711459905000},"page":"101754","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A case of hypophosphatemia and elevated intact fibroblast growth factor 23 levels after short-term saccharated ferric oxide administration in a young woman and database analysis of adverse drug reactions in Japan"],"prefix":"10.1016","volume":"21","author":[{"given":"Teruhisa","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Sakazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Takimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Ishitsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2024.101754_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.733793","article-title":"Cortisol and phosphate homeostasis: Cushing\u2019s syndrome is associated with reversible hypophosphatemia","volume":"12","author":"Bosman","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"19","key":"10.1016\/j.bonr.2024.101754_bb0010","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJMra1401038","article-title":"Iron-deficiency anemia","volume":"372","author":"Camaschella","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bonr.2024.101754_bb0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41581-019-0189-5","article-title":"FGF23 at the crossroads of phosphate, iron economy and erythropoiesis","volume":"16","author":"Edmonston","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"382","key":"10.1016\/j.bonr.2024.101754_bb0020","article-title":"Effect and timing of operative treatment for teratoma associated N-methyl\u2011d-aspartate receptor-antibody encephalitis: a systematic review with meta-analysis","volume":"15","author":"Erlebah","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bonr.2024.101754_bb0025","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/cc9215","article-title":"Treatment of hypophosphatemia in the intensive care unit: a review","volume":"14","author":"Geerse","year":"2010","journal-title":"Crit. Care"},{"issue":"7","key":"10.1016\/j.bonr.2024.101754_bb0030","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1007\/s12325-021-01770-2","article-title":"Intravenous Iron-induced hypophosphatemia: an emerging syndrome","volume":"38","author":"Glaspy","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.bonr.2024.101754_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/468675","article-title":"Intravenous iron administration and hypophosphatemia in clinical practice","author":"Hardy","year":"2015","journal-title":"Int. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.bonr.2024.101754_bb0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12185-018-2501-8","article-title":"Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study","volume":"109","author":"Ikuta","year":"2019","journal-title":"Int. J. Hematol."},{"issue":"5","key":"10.1016\/j.bonr.2024.101754_bb0045","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12185-022-03401-0","article-title":"Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study","volume":"116","author":"Kawabata","year":"2022","journal-title":"Int. J. Hematol."},{"issue":"7","key":"10.1016\/j.bonr.2024.101754_bb0050","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/qjmed\/hcq039","article-title":"Medication-induced hypophosphatemia: a review","volume":"103","author":"Liamis","year":"2010","journal-title":"QJM Mon J Assoc Physicians."},{"issue":"10270","key":"10.1016\/j.bonr.2024.101754_bb0055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(20)32594-0","article-title":"Iron deficiency","volume":"397","author":"Pasricha","year":"2021","journal-title":"Lancet Lond Engl."},{"issue":"3","key":"10.1016\/j.bonr.2024.101754_bb0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bonr.2024.101754_bb0065","first-page":"98","article-title":"Iron deficiency anemia: evaluation and management","volume":"87","author":"Short","year":"2013","journal-title":"Am. Fam. Physician"},{"issue":"6","key":"10.1016\/j.bonr.2024.101754_bb0070","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/jbmr.4558","article-title":"Osteomalacia as a complication of intravenous Iron infusion: a systematic review of case reports","volume":"37","author":"Vilaca","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"23","key":"10.1016\/j.bonr.2024.101754_bb0075","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124486","article-title":"Randomized trial of intravenous iron-induced hypophosphatemia","volume":"3","author":"Wolf","year":"2018","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.bonr.2024.101754_bb0080","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of Iron Isomaltoside vs ferric Carboxymaltose on hypophosphatemia in Iron-deficiency Anemia: two randomized clinical trials","volume":"323","author":"Wolf","year":"2020","journal-title":"JAMA"}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187224000214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187224000214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T11:54:26Z","timestamp":1718538866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187224000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":16,"alternative-id":["S2352187224000214"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2024.101754","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of hypophosphatemia and elevated intact fibroblast growth factor 23 levels after short-term saccharated ferric oxide administration in a young woman and database analysis of adverse drug reactions in Japan","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2024.101754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101754"}}